| Patents for C07C 217 - Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton (13,958) |
|---|
| 08/28/2003 | US20030161808 Ester quaternary mixtures |
| 08/27/2003 | EP1159252B1 Method for the racemization of optically active amines |
| 08/27/2003 | CN1439035A Crosslinkable elastomer composition |
| 08/27/2003 | CN1438883A Beta Secretase inhibitors |
| 08/27/2003 | CN1119319C Asymmetric synthesis of (-) 6-chloro-4-cyclopropyl-ethynyl-4-trifluoromethyl-1, 4dihydro-2H-3, 1-benzoxazin-2-one |
| 08/26/2003 | US6610806 Initiators include a metal atom and a ligand having two group 15 atoms and a group of 16 atoms, ligand is bonded to the metal atom through two anionic or covalant bonds and a co-ordination bond |
| 08/26/2003 | US6610805 Catalyst ligands, catalytic metal complexes and processes using same |
| 08/26/2003 | US6610705 Process for the preparation of diaryl naphthyl methanes |
| 08/26/2003 | US6610702 Ammonium salts of inositol hexaphosphate, and uses thereof |
| 08/21/2003 | WO2003067983A1 Surfactants and surfactant compositions |
| 08/21/2003 | WO2002042259A3 Methods of synthesizing and using derivatives of [2-(2-aminoethoxy)ethoxy] acetic acid |
| 08/21/2003 | WO2002002512A3 Compounds to treat alzheimer's disease |
| 08/21/2003 | US20030158266 Particularly septic shock |
| 08/21/2003 | US20030158259 Drugs for treating obesity and diabetes and animal feed additives |
| 08/21/2003 | US20030158253 Ethers of O-Desmethyl venlafaxine |
| 08/21/2003 | US20030158242 Salt with a sugar substitute, especially saccharin, cyclamate or acesulfame. |
| 08/21/2003 | US20030158185 Novel use of phenylheteroakylamine derivatives |
| 08/21/2003 | US20030158176 Quaternary ammonium compounds |
| 08/21/2003 | US20030158033 Single site-like catalysts |
| 08/21/2003 | CA2475686A1 Surfactants and surfactant compositions |
| 08/20/2003 | EP1335899A2 Substituted alkyldiamines as inhibitors of plasmepsin or related proteases |
| 08/20/2003 | EP0883598B1 Use of aminophenol derivatives in oxidative hair dyes |
| 08/20/2003 | EP0776330B1 Photolabile compounds and methods for their use |
| 08/20/2003 | CN1437576A Substituted aminomethyl-phenyl-cyclohexane derivatives |
| 08/19/2003 | US6608228 Fluorenyl and dibenzosuberenyl moieties; efficient |
| 08/19/2003 | US6608120 Cyclopolymerized under the influence of ultraviolet or thermal radiation; coatings or binders |
| 08/19/2003 | US6608066 Tissue factor antagonists and methods of use thereof |
| 08/14/2003 | WO2003066570A1 Transition-metal-catalyzed carbon-nitrogen bond-forming methods using carbene ligands |
| 08/14/2003 | WO2003066564A1 Process for producing (r)-3-hydroxy-3-(2-phenylethyl)hexanoic acid and its intermediate |
| 08/14/2003 | US20030153780 Water-soluble specialty surfactants to lower the surface tension of water to <20 dynes/cm.; reacting amines with allyl glycidyl ether, followed by reaction with a perfluoroalkyl iodide; oily surfaces; coatings for addition polymers |
| 08/14/2003 | US20030153631 Alkyl glycidyl ether-capped diamine foam controlling agents |
| 08/14/2003 | US20030153597 Therapeutic treatment of respiratory disorders such as asthma and chronic obstructive pulmonary disease, nervous system disorders and cardiovascular disorders |
| 08/14/2003 | CA2475332A1 Process for producing (r)-3-hydroxy-3-(2-phenylethyl)hexanoic acid and its intermediate |
| 08/13/2003 | EP1334083A2 1,4-disubstituted benzenes as insecticides |
| 08/13/2003 | EP1334082A2 Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof |
| 08/13/2003 | CN1435454A Alkyl glycidyl ether end-capped diamine compound foam control agent |
| 08/13/2003 | CN1117727C Process for hydrogenation of imines |
| 08/12/2003 | US6605642 Inhibitors of formation of advanced glycation endproducts (AGES) |
| 08/07/2003 | WO2003064372A1 2-adamantylalkylamines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission |
| 08/07/2003 | WO2003063790A2 Additives and products including oligoesters |
| 08/07/2003 | US20030149290 Aminostyrylanthracene compound, synthetic intermediate thereof, and process for production thereof |
| 08/07/2003 | US20030149250 Labeled compounds useful in imaging amyloid deposits and useful for inhibiting the aggregation of amyloid protein to form amyloid deposit |
| 08/07/2003 | US20030149107 For therapy of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis |
| 08/07/2003 | US20030149052 Side effect reduction |
| 08/07/2003 | US20030149003 Functionalized stilbene derivatives as improved vascular targeting agents |
| 08/06/2003 | EP1332139A2 Anticancer agents based on regulation of protein prenylation |
| 08/06/2003 | EP1332126A1 Novel coupling components for oxidation dyes |
| 08/06/2003 | EP1331918A1 Primary intermediates for oxidative coloration of hair |
| 08/06/2003 | EP1084103B1 New 3-aryl-2-hydroxypropionic acid derivative (i) |
| 08/06/2003 | CN1434805A 选择性神经激肽拮抗剂 Selective neurokinin antagonists |
| 08/05/2003 | US6602901 Antidiabetic agents, obesity |
| 08/05/2003 | US6602888 Use of α1C specific compounds to treat benign prostatic hyperplasia |
| 08/05/2003 | US6602302 Substituted 1,4 diaminobenzene compounds and oxidation dye precursor compositions containing same |
| 07/31/2003 | WO2003061552A2 Novel process for the preparation of substantially pure 5-(3,5-dimethylphenoxy)methyl-2-oxazolidinone |
| 07/31/2003 | US20030144526 Calcium receptor-active compounds |
| 07/31/2003 | US20030144275 Decyclization of oxabenzonorbornadienes or azabicyclic compounds in the presence of catalysts to form naphthalenes, such as 2-methoxy-1,2-dihydronaphthalen-1-ol, used as analgesics, anticarcinogens or viricides; catalysis |
| 07/31/2003 | US20030143559 A modified estrogen receptor alpha ligand binding domain containing an amino acid modification in region 1, at region 2, or atleast one amino acid modifiation in both of regions, and these domain interacts with a nonendogenous ligand |
| 07/31/2003 | US20030143430 Durability; decreased driving voltage |
| 07/30/2003 | EP1330427A1 Crystalline forms of venlafaxine hydrochloride |
| 07/30/2003 | EP1252216B1 Amino organic substances |
| 07/30/2003 | EP1150941B1 Method for the racemization of optically active amines |
| 07/30/2003 | EP1043305B1 Amine derivatives and organic electroluminescent device made by using the same |
| 07/30/2003 | EP0783482B1 Cationic transport reagents |
| 07/30/2003 | CN1433401A New phenalkyloxy-phenyl derivatives |
| 07/29/2003 | US6600074 Perfluoroalkylated aniline compound and process for producing the same |
| 07/29/2003 | US6599920 Antiestrogenic compound having fewer or no estrogen agonist properties on reproductive tissues |
| 07/24/2003 | WO2003059864A2 Pheny(alkyl)carboxylic acid derivatives and dionic phenylalkylheterocyclic derivatives and their use as medicines with serum glucose and/or serum lipid lowering activity |
| 07/24/2003 | US20030139623 Catalyzing the decarboxylation and hydroxylation in the presence of an aqueous base and a phase transfer catalyst |
| 07/24/2003 | US20030139602 Deetherification forming a 6-hydroxy-2-amide-alkyl-tetralin hydrochloride salt for treating Alzheimer's disease |
| 07/24/2003 | US20030139376 Lipoxin A4 analogs |
| 07/24/2003 | US20030138847 Compressed tablets comprising divinylbenzene-styrene beads within disintegrate in solvent; combinatorial chemistry |
| 07/24/2003 | CA2472209A1 Pheny(alkyl)carboxylic acid derivatives and dionic phenylalkylheterocyclic derivatives and their use as medicines with serum glucose and/or serum lipid lowering activity |
| 07/23/2003 | CN1431192A Dumbbell form aniline oligomer and its synthesizing method |
| 07/22/2003 | US6596741 Compounds of formula I exhibit activity as serotonin, norepinephrine, and dopamine reuptake inhibitors and can be used in the treatment of central nervous system and other disorders. |
| 07/17/2003 | WO2003057164A2 Compounds for delivering substances into cells |
| 07/17/2003 | US20030134989 Forming allyloxycarbonyl-, fluorenylmethoxycarbonyl-, t-butoxycarbonyl- and benzyloxycarbonyl derivatives by aziding (chloroethoxy)ethoxyethanol, reacting with triphenyl phosphine and H2O, reacting with a chloroformate, oxidizing |
| 07/17/2003 | US20030134423 Lipid aggregates (liposomes) for transfection of nucleic acids |
| 07/17/2003 | US20030134147 Dendrimers,e.g.,(styryl)n phenyleneamines, allows direct control of the microscopic packing through chemical modification to provide a correlation between molecular structure of the molecules and device semiconductors |
| 07/17/2003 | US20030131422 Primary intermediates for oxidative coloration of hair |
| 07/16/2003 | EP1326824A1 Pharmaceutical compounds |
| 07/16/2003 | EP0984920B1 Novel method for preparing 2-trifluoro-methoxy-aniline |
| 07/15/2003 | US6593497 β2-adrenergic receptor agonists |
| 07/15/2003 | US6593374 Such as 3-(3'4'5'-trimethoxybenzoyl)-2-(3'benzylphosphate 4'methoxyphenyl)-6-methoxybenzo(b)thiophene; functionalized to prepare phosphate esters, phosphate salts, and phosphoramidates useful as antitumor agents |
| 07/10/2003 | WO2003055474A1 Treatment of faecal incontinence and other conditions with 1r, 2s-methoxamine |
| 07/10/2003 | US20030130236 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 07/10/2003 | US20030130165 Method for treating neurodegenerative disorders |
| 07/10/2003 | US20030130124 Uracil compounds and use thereof |
| 07/09/2003 | EP0845023B1 Polyalkylphenoxyaminoalkanes and fuel compositions containing the same |
| 07/09/2003 | CN1113874C Benzocycloalkylazolethione derivatives |
| 07/09/2003 | CN1113856C New [(3-alkoxy-phenoxy)-ethyl] dialkylamine derivatives and their use as local anaesthetics |
| 07/08/2003 | US6590120 Reacting alkali or earth alkali metal salt of maleic acid with N-substituted diethanolamine, in which two ethanol groups of diethanolamine react while substituent is unreactive with maleic acid salt |
| 07/08/2003 | CA2264372C New benzocyclobutane compounds, their method of preparation, and pharmaceutical compositions containing them |
| 07/03/2003 | WO2003053994A1 Tetrahydrobenzfluorene derivatives |
| 07/03/2003 | US20030125329 Treating atherosclerosis and other coronary artery diseases |
| 07/03/2003 | US20030125328 Treating atherosclerosis and other coronary artery diseases |
| 07/02/2003 | EP1322596A1 Zwitterionic tachykinin receptor antagonists |
| 07/02/2003 | EP1322593A1 O-substituted 6-methyl-tramadol derivatives |
| 07/02/2003 | EP1322592A1 Substituted 1-aminobutan-3-ol derivatives |
| 07/02/2003 | EP1322590A1 5-amino-1-pentene-3-ol substituted derivatives |
| 07/02/2003 | EP0751952B1 Displacement chromatography of proteins using low molecular weight displacers |